Meimei Wang, Hui Li, Chaoshan Han, Yunxi Chen, Lihao He, Min Xie, Hind Lal, Vladimir G Fast, Douglas R Moellering, Jianyi Zhang, Rui Lu, Martin Young, Yang Zhou
{"title":"心肌细胞Elmsan1缺失导致年龄依赖性心功能障碍和寿命缩短。","authors":"Meimei Wang, Hui Li, Chaoshan Han, Yunxi Chen, Lihao He, Min Xie, Hind Lal, Vladimir G Fast, Douglas R Moellering, Jianyi Zhang, Rui Lu, Martin Young, Yang Zhou","doi":"10.1152/ajpheart.00810.2024","DOIUrl":null,"url":null,"abstract":"<p><p>Histone deacetylase (HDAC) complexes regulate pathological gene programs during heart disease progression. The recently identified mitotic deacetylase complex (MiDAC), which includes DNTTIP1, ELMSAN1, and HDAC1/2, remains the least characterized among these complexes. ELMSAN1 has been implicated in left ventricular remodeling, and its global deletion in mice leads to heart malformation. To investigate its role in mouse heart, we generated cardiomyocyte-specific <i>Elmsan1</i> knockout (ELM cKO) using αMHC-driven Cre recombinase. We analyzed both male and female animals across three experimental groups: αMHC-Cre (Cre control), ELM fl/fl (floxed control), and ELM cKO. In male ELM cKO mice, ejection fraction (EF) was significantly reduced by 12 wk (45.64 ± 3.12%), compared with αMHC-Cre (55.91 ± 1.29%) and ELM fl/fl (59.16 ± 3.70%) controls. By 24 wk, EF declined further to 20.79 ± 4.52%, representing a reduction of 46.4% (<i>P</i> < 0.01) and 62.1% (<i>P</i> < 0.0001) compared with αMHC-Cre and ELM fl/fl mice, respectively. The heart failure phenotype in ELM cKO mice was supported by cardiomyocyte hypertrophy morphology, ventricular dilation, and shortened lifespan. Female ELM cKO mice exhibited similar defects with delayed onset. To investigate early molecular changes, we performed RNA sequencing on presymptomatic hearts from 8-wk-old mice. A total of 1,055 genes were differentially expressed in ELM ckO hearts, with 460 upregulated and 595 downregulated. Gene enrichment analysis revealed suppression of tricarboxylic acid cycle and key cardiac genes. These transcriptional changes were accompanied by decreased mitochondrial respiratory chain complex proteins, ultrastructural mitochondrial abnormalities, and impaired calcium handling. Our study demonstrates that Elmsan1 is pivotal for maintaining heart function and hemostasis with advanced age.<b>NEW & NOTEWORTHY</b> Our study demonstrates that Elmsan1, a unique component of the mitotic deacetylase complex (MiDAC), is essential for maintaining cardiac function. Loss of <i>Elmsan1</i> in cardiomyocytes leads to age-related cardiac dysfunction and mitochondrial abnormalities in mice. Using a cardiomyocyte-specific <i>Elmsan1</i> knockout model, we show that Elmsan1 preserves adult heart function by regulating genes involved in calcium handling and energy metabolism, underscoring the specific role of MiDAC in maintaining heart hemostasis.</p>","PeriodicalId":7692,"journal":{"name":"American journal of physiology. Heart and circulatory physiology","volume":" ","pages":"H315-H329"},"PeriodicalIF":4.1000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Loss of Elmsan1 in cardiomyocytes leads to age-dependent cardiac dysfunction and reduced lifespan.\",\"authors\":\"Meimei Wang, Hui Li, Chaoshan Han, Yunxi Chen, Lihao He, Min Xie, Hind Lal, Vladimir G Fast, Douglas R Moellering, Jianyi Zhang, Rui Lu, Martin Young, Yang Zhou\",\"doi\":\"10.1152/ajpheart.00810.2024\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Histone deacetylase (HDAC) complexes regulate pathological gene programs during heart disease progression. The recently identified mitotic deacetylase complex (MiDAC), which includes DNTTIP1, ELMSAN1, and HDAC1/2, remains the least characterized among these complexes. ELMSAN1 has been implicated in left ventricular remodeling, and its global deletion in mice leads to heart malformation. To investigate its role in mouse heart, we generated cardiomyocyte-specific <i>Elmsan1</i> knockout (ELM cKO) using αMHC-driven Cre recombinase. We analyzed both male and female animals across three experimental groups: αMHC-Cre (Cre control), ELM fl/fl (floxed control), and ELM cKO. In male ELM cKO mice, ejection fraction (EF) was significantly reduced by 12 wk (45.64 ± 3.12%), compared with αMHC-Cre (55.91 ± 1.29%) and ELM fl/fl (59.16 ± 3.70%) controls. By 24 wk, EF declined further to 20.79 ± 4.52%, representing a reduction of 46.4% (<i>P</i> < 0.01) and 62.1% (<i>P</i> < 0.0001) compared with αMHC-Cre and ELM fl/fl mice, respectively. The heart failure phenotype in ELM cKO mice was supported by cardiomyocyte hypertrophy morphology, ventricular dilation, and shortened lifespan. Female ELM cKO mice exhibited similar defects with delayed onset. To investigate early molecular changes, we performed RNA sequencing on presymptomatic hearts from 8-wk-old mice. A total of 1,055 genes were differentially expressed in ELM ckO hearts, with 460 upregulated and 595 downregulated. Gene enrichment analysis revealed suppression of tricarboxylic acid cycle and key cardiac genes. These transcriptional changes were accompanied by decreased mitochondrial respiratory chain complex proteins, ultrastructural mitochondrial abnormalities, and impaired calcium handling. Our study demonstrates that Elmsan1 is pivotal for maintaining heart function and hemostasis with advanced age.<b>NEW & NOTEWORTHY</b> Our study demonstrates that Elmsan1, a unique component of the mitotic deacetylase complex (MiDAC), is essential for maintaining cardiac function. Loss of <i>Elmsan1</i> in cardiomyocytes leads to age-related cardiac dysfunction and mitochondrial abnormalities in mice. Using a cardiomyocyte-specific <i>Elmsan1</i> knockout model, we show that Elmsan1 preserves adult heart function by regulating genes involved in calcium handling and energy metabolism, underscoring the specific role of MiDAC in maintaining heart hemostasis.</p>\",\"PeriodicalId\":7692,\"journal\":{\"name\":\"American journal of physiology. Heart and circulatory physiology\",\"volume\":\" \",\"pages\":\"H315-H329\"},\"PeriodicalIF\":4.1000,\"publicationDate\":\"2025-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American journal of physiology. Heart and circulatory physiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1152/ajpheart.00810.2024\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/6/30 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of physiology. Heart and circulatory physiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1152/ajpheart.00810.2024","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/30 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Loss of Elmsan1 in cardiomyocytes leads to age-dependent cardiac dysfunction and reduced lifespan.
Histone deacetylase (HDAC) complexes regulate pathological gene programs during heart disease progression. The recently identified mitotic deacetylase complex (MiDAC), which includes DNTTIP1, ELMSAN1, and HDAC1/2, remains the least characterized among these complexes. ELMSAN1 has been implicated in left ventricular remodeling, and its global deletion in mice leads to heart malformation. To investigate its role in mouse heart, we generated cardiomyocyte-specific Elmsan1 knockout (ELM cKO) using αMHC-driven Cre recombinase. We analyzed both male and female animals across three experimental groups: αMHC-Cre (Cre control), ELM fl/fl (floxed control), and ELM cKO. In male ELM cKO mice, ejection fraction (EF) was significantly reduced by 12 wk (45.64 ± 3.12%), compared with αMHC-Cre (55.91 ± 1.29%) and ELM fl/fl (59.16 ± 3.70%) controls. By 24 wk, EF declined further to 20.79 ± 4.52%, representing a reduction of 46.4% (P < 0.01) and 62.1% (P < 0.0001) compared with αMHC-Cre and ELM fl/fl mice, respectively. The heart failure phenotype in ELM cKO mice was supported by cardiomyocyte hypertrophy morphology, ventricular dilation, and shortened lifespan. Female ELM cKO mice exhibited similar defects with delayed onset. To investigate early molecular changes, we performed RNA sequencing on presymptomatic hearts from 8-wk-old mice. A total of 1,055 genes were differentially expressed in ELM ckO hearts, with 460 upregulated and 595 downregulated. Gene enrichment analysis revealed suppression of tricarboxylic acid cycle and key cardiac genes. These transcriptional changes were accompanied by decreased mitochondrial respiratory chain complex proteins, ultrastructural mitochondrial abnormalities, and impaired calcium handling. Our study demonstrates that Elmsan1 is pivotal for maintaining heart function and hemostasis with advanced age.NEW & NOTEWORTHY Our study demonstrates that Elmsan1, a unique component of the mitotic deacetylase complex (MiDAC), is essential for maintaining cardiac function. Loss of Elmsan1 in cardiomyocytes leads to age-related cardiac dysfunction and mitochondrial abnormalities in mice. Using a cardiomyocyte-specific Elmsan1 knockout model, we show that Elmsan1 preserves adult heart function by regulating genes involved in calcium handling and energy metabolism, underscoring the specific role of MiDAC in maintaining heart hemostasis.
期刊介绍:
The American Journal of Physiology-Heart and Circulatory Physiology publishes original investigations, reviews and perspectives on the physiology of the heart, vasculature, and lymphatics. These articles include experimental and theoretical studies of cardiovascular function at all levels of organization ranging from the intact and integrative animal and organ function to the cellular, subcellular, and molecular levels. The journal embraces new descriptions of these functions and their control systems, as well as their basis in biochemistry, biophysics, genetics, and cell biology. Preference is given to research that provides significant new mechanistic physiological insights that determine the performance of the normal and abnormal heart and circulation.